Canadian Hospital Specialties Limited Joins AdvaMed®, the World’s Leading Medical Technology Trade Association
- Canadian Hospital Specialties Limited
February 9, 2022 — Canadian Hospital Specialties Limited (CHS) announced today that it has joined the Advanced Medical Technology Association® (AdvaMed®), the world’s leading trade association representing more than 400 medical device manufacturers around the world. Read more…
Related Reading
News / Coverage & Payment / Diabetes / Diagnostics / Digital Health / Government & Legislative Affairs / Health Access
ICYMI: AdvaMed Op-ed on the Vital Role of Medtech in Making Americans Healthy Again
July 30, 2025
WASHINGTON, D.C. – In a new op-ed in The Washington Times, Scott Whitaker, president and CEO of AdvaMed, the Medtech Association, laid out medtech’s vital role in the Trump administration’s “Make America Healthy Again” initiative, calling for policies that ensure faster, broader access to lifesaving medtech.
News / Diagnostics / Digital Health / Government & Legislative Affairs / Medical Imaging
AdvaMed Welcomes White House’s “America’s AI Action Plan”
July 23, 2025
WASHINGTON, D.C.—Scott Whitaker, president and CEO of AdvaMed, the medtech association, issued the following statement on the White House’s “America’s AI Action Plan”:
Resource / Emerging Policy Response Resources / Tariffs
Tariff-related Litigation Update – 7/18
July 18, 2025
Member-only overview of IEEPA reciprocal & “fentanyl” tariffs under EO 14257, summarizing key federal court challenges and rulings through July 18, 2025.
Resource / Emerging Policy Response Resources / Government & Legislative Affairs / Tariffs
AdvaMed® Advancements: Q2 2025 Report
July 17, 2025
Discover our Q2 report highlighting key industry wins, tariff updates, and strategic progress driving medtech innovation and advocacy forward.
Resource / Global & Trade / research & policy papers / Workforce Advancement
U.S. Medtech Manufacturing: Driving Innovation, Jobs, & Global Impact
July 17, 2025
Explore how U.S. medtech manufacturing drives $250B in output, supports 3M jobs, leads in R&D, and fuels global exports.
Resource / Emerging Policy Response Resources / Tariffs
Tariff-related Litigation Update – 7/11
July 11, 2025
Member-only overview of IEEPA reciprocal & “fentanyl” tariffs under EO 14257, summarizing key federal court challenges and rulings through July 11, 2025.
Blog / Diabetes / Diagnostics / Digital Health / Medical Imaging / Orthopedic / Radiation Therapy
Advancing Access to Patient Care: The Importance of Advocacy on the Hill
July 10, 2025
AdvaMed’s 2024 Medtech Showcase on Capitol Hill featured 37 companies and 40+ innovations, connecting medtech leaders with U.S. policymakers.
Event / Emerging Policy Response Resources / Global & Trade / Government & Legislative Affairs / Supply Chain / Tariffs
The Kennedy v Braidwood Ruling: What’s Next for MedTech
July 17, 2025
2:00 PM – 3:30 PM
Join AdvaMed and Reed Smith experts to explore how the Supreme Court’s ACA ruling in Braidwood could shape preventive care and MedTech policy.